Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Gastritis-I: Introduction and Types01:27

Gastritis-I: Introduction and Types

380
Gastritis, defined by the inflammation or irritation of the stomach lining or gastric mucosa, manifests in several distinct forms: acute, chronic, reactive, and a specific subtype known as autoimmune metaplastic atrophic gastritis.
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
380
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

115
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
115
Assessment of the Gastrointestinal System I: Subjective Data01:17

Assessment of the Gastrointestinal System I: Subjective Data

184
Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
184
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

232
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
232
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

322
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
322
Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

73
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
73

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gout therapy updated.

Therapeutic advances in musculoskeletal disease·2025
Same author

Synchronising an IMX219 image sensor and AS7265x spectral sensor to make a novel low-cost spectral camera.

HardwareX·2024
Same author

Annals On Call - Gout Diagnosis and Management: What's New?

Annals of internal medicine·2024
Same author

Vitamin B12 status and hyperhomocysteinemia in patients with Rheumatoid arthritis treated with methotrexate and folic acid.

The American journal of the medical sciences·2024
Same author

Serum Urate and Its Association With Gout Flares.

JAMA·2024
Same author

Self-management of gout using a mobile app.

The Lancet. Rheumatology·2024

Related Experiment Video

Updated: Jun 27, 2025

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

7.2K

Investigating gout flares: beyond a definition.

Charles Sutherland1, Angelo L Gaffo2,3

  • 1Tinsley Harrison Internal Medicine Residency Program.

Current Opinion in Rheumatology
|May 2, 2024
PubMed
Summary
This summary is machine-generated.

Gout flares significantly impact patients, and recent studies have validated definitions and used technology to monitor them. Improved measurement methods are needed to fully capture the disease burden for better intervention development.

More Related Videos

Synovial Fluid Analysis to Identify Osteoarthritis
07:51

Synovial Fluid Analysis to Identify Osteoarthritis

Published on: October 20, 2022

4.4K
Diagnosis of Musculus Gastrocnemius Tightness - Key Factors for the Clinical Examination
08:43

Diagnosis of Musculus Gastrocnemius Tightness - Key Factors for the Clinical Examination

Published on: July 7, 2016

14.3K

Related Experiment Videos

Last Updated: Jun 27, 2025

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

7.2K
Synovial Fluid Analysis to Identify Osteoarthritis
07:51

Synovial Fluid Analysis to Identify Osteoarthritis

Published on: October 20, 2022

4.4K
Diagnosis of Musculus Gastrocnemius Tightness - Key Factors for the Clinical Examination
08:43

Diagnosis of Musculus Gastrocnemius Tightness - Key Factors for the Clinical Examination

Published on: July 7, 2016

14.3K

Area of Science:

  • Rheumatology
  • Clinical Trials
  • Patient-Reported Outcomes

Background:

  • Gout flares are a major contributor to the overall burden of gout for patients.
  • Gout flares are recognized as a core domain for long-term gout studies by Outcome Measures in Rheumatology.
  • Validated classification criteria for gout exist, prompting further investigation into defining and characterizing gout flares.

Purpose of the Study:

  • To summarize efforts in defining and characterizing gout flares in clinical studies.
  • To review recent advancements in gout flare assessment.
  • To discuss the challenges and potential improvements in measuring gout flare burden.

Main Methods:

  • Review of recent clinical studies and qualitative analyses.
  • Examination of validated gout flare definitions.
  • Assessment of technological applications for monitoring gout flares.

Main Results:

  • A validated definition of a gout flare has been established and used in new clinical studies.
  • Technology is being employed to monitor gout flares and their impact on patients' lives.
  • Qualitative research has provided insights into the disease burden experienced by patients.

Conclusions:

  • While core outcome domains are established, challenges remain in measuring and reporting gout flares in long-term trials.
  • Current instruments may not fully capture the disease burden experienced by gout patients.
  • Combining binary flare data with comprehensive, longitudinal disease burden measurements could enhance accuracy and aid intervention development.